Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people report feeling more energy on Wegovy once their body adjusts to treatment, though the first few weeks often tell a different story. Energy levels during semaglutide treatment follow a recognisable pattern: an initial dip driven by nausea, reduced food intake and the adjustment phase, followed (for many people) by a gradual lift as weight falls and appetite stabilises. Wegovy is a prescription-only medicine; a clinical assessment with a GPhC-registered prescriber decides whether it is suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The opening weeks of Wegovy treatment are not when most people feel a surge in vitality. Nausea, reduced appetite and occasional vomiting are among the most common side effects as your body adjusts to semaglutide; they typically peak around a dose increase and ease within days to a couple of weeks. Eating considerably less than usual (which the medicine is designed to bring about) means taking in fewer calories, and that alone can make you feel sluggish.
This is a calibration phase, not a warning sign. The semaglutide overview on our site covers the full side-effect picture in more detail, but the short version is this: GI symptoms are most noticeable at the start and after each upward titration. They pass for most people. Trying to push hard at the gym during this window often backfires, light activity is fine, but demanding exercise before your appetite and energy have stabilised can deepen the fatigue rather than lift it.
One practical note: if you are taking Wegovy and also relying on oral medicines (including some contraceptives), slower gastric emptying may affect their absorption. Check the full picture with your prescriber rather than guessing.
Once nausea settles and eating patterns find a new rhythm, the energy picture tends to shift. People who were previously carrying significant excess weight often notice that everyday tasks feel lighter, not because the medicine is stimulating them, but because the body is doing less work. Reduced joint load, a calmer cardiovascular system and, frequently, better sleep all feed into a quieter, steadier kind of energy rather than a caffeine-style lift. If you have been asking yourself whether Wegovy will give you energy, this gradual, cumulative shift is typically what people are describing rather than any sudden stimulant effect.
Sleep is worth flagging specifically. Excess weight is closely linked to disrupted sleep and obstructive sleep apnoea. As weight falls, sleep quality can improve meaningfully, and the difference between seven hours of fragmented sleep and seven hours of solid rest shows up clearly the next morning before the kettle even goes on. This is one of the less-discussed benefits of semaglutide treatment, but it is one that patients mention frequently.
Protein adequacy becomes important here. The NHS semaglutide information page advises following a reduced-calorie diet alongside treatment, but with a smaller appetite it is easy to eat too little protein. That shortfall is a reliable driver of the muscle fatigue and flat mood that some people attribute to Wegovy itself. Aim to include a protein source at every meal, even small ones.
For people who tolerate Wegovy well and continue losing weight, the energy gains tend to compound over months rather than arriving in one recognisable moment. Less weight, better sleep, reduced inflammation and improved metabolic markers (blood pressure, blood glucose, cholesterol) all contribute. Clinical trial data from the STEP programme (including the STEP 1 trial published in the New England Journal of Medicine) documented broad improvements in cardiometabolic health over 68 weeks at the 2.4mg maintenance dose, which underpin the physical energy improvements people report. Our guide on whether Wegovy does give you energy explores this longer-term picture in more detail if you want to understand the mechanisms behind it.
That said, fatigue that is worsening rather than improving, or that arrives suddenly after a period of feeling fine, is not something to dismiss. Persistent, severe tiredness can signal dehydration from ongoing GI symptoms, inadequate nutrition, or something unrelated to Wegovy entirely. Your prescriber needs to know. At nume, sorry, at nume, clinical aftercare runs seven days a week precisely because questions like this come up between doses, not just at the point of ordering.
If you are weighing up whether the wider treatment experience is right for you, the Wegovy price comparison page lays out what different providers typically include, useful context when you are thinking about ongoing clinical support, not just the first pen. And if low energy is your dominant concern rather than a passing phase, our page on low energy on Wegovy goes deeper on what is driving it and what to do, as does our dedicated resource on managing a lack of energy on Wegovy, which covers practical steps you can take between prescriber appointments. A prescriber who knows your full history is better placed than any general guide to tell you whether what you are experiencing is expected or warrants a closer look, speak to our prescribers if you are unsure.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.